{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:07:16Z","timestamp":1789913236203,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,12,21]],"date-time":"2007-12-21T00:00:00Z","timestamp":1198195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00192-007-0515-5","type":"journal-article","created":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T08:55:31Z","timestamp":1198140931000},"page":"717-721","source":"Crossref","is-referenced-by-count":85,"title":["Hyaluronan treatment of interstitial cystitis\/painful bladder syndrome"],"prefix":"10.1007","volume":"19","author":[{"given":"Claus R.","family":"Riedl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurosch L.","family":"Daha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nike","family":"Morakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Pfl\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,21]]},"reference":[{"key":"515_CR1","first-page":"6, 7, 16, 17","volume":"18","author":"JP Merwe Van de","year":"2006","unstructured":"Van de Merwe JP, Nordling J (2006) Interstitial cystitis: definitions and confusable diseases. ESSIC meeting 2005, Baden. Eur Urol Today 18:6, 7, 16, 17","journal-title":"Eur Urol Today"},{"key":"515_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.eeus.2005.10.001","volume":"4","author":"G Karsenty","year":"2006","unstructured":"Karsenty G, AlTaweel W, Hajebrahimi S, Corcos J (2006) Efficacy of interstitial cystitis treatments: a review. EAU-EBU Update Series 4:47\u201361","journal-title":"EAU-EBU Update Series"},{"key":"515_CR3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0022-5347(17)38437-9","volume":"145","author":"CL Parsons","year":"1991","unstructured":"Parsons CL, Lilly JD, Stein P (1991) Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 145:732\u2013735","journal-title":"J Urol"},{"key":"515_CR4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF01901246","volume":"7","author":"G Hohlbrugger","year":"1996","unstructured":"Hohlbrugger G (1996) Leaky urothelium and\/or vesical ischemia enable urinary potassium to cause idiopathic urgency\/frequency syndrome and urge incontinence. Int Urogynecol J Pelvic Floor Dysfunction 7:242\u2013255","journal-title":"Int Urogynecol J Pelvic Floor Dysfunction"},{"key":"515_CR5","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0022-5347(17)32495-3","volume":"152","author":"RE Hurst","year":"1994","unstructured":"Hurst RE, Zebrowski R (1994) Identification of proteoglycans present at high density on bovine and human bladder luminal surface. J Urol 152:1641\u20131644","journal-title":"J Urol"},{"key":"515_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00182044","volume":"12","author":"RE Hurst","year":"1994","unstructured":"Hurst RE (1994) Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract. World J Urol 12:3\u201310","journal-title":"World J Urol"},{"key":"515_CR7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1054\/mehy.1997.0652","volume":"52","author":"AL Russell","year":"1999","unstructured":"Russell AL (1999) Glycosaminoglycan (GAG) deficiency in protective barrier as an underlying, primary cause of ulcerative colitis, Crohn\u2019s disease, interstitial cystitis and possibly Reiter\u2019s syndrome. Med hypotheses 52:297\u2013301","journal-title":"Med hypotheses"},{"key":"515_CR8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.mou.0000232048.81965.16","volume":"16","author":"BR Toft","year":"2006","unstructured":"Toft BR, Nordling J (2006) Recent developments of intravesical therapy of painful bladder syndrome\/interstitial cystitis: a review. Curr Opin Urol 16:268\u2013272","journal-title":"Curr Opin Urol"},{"key":"515_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-5347(01)65933-0","volume":"156","author":"A Morales","year":"1996","unstructured":"Morales A, Emerson L, Nickel JC, Lundie M (1996) Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 156:45\u201348","journal-title":"J Urol"},{"key":"515_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0090-4295(97)00110-6","volume":"50","author":"P Hwang","year":"1997","unstructured":"Hwang P, Auclair B, Beechinor D, Diment M, Einarson TR (1997) Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis. Urology 50:39\u201343","journal-title":"Urology"},{"key":"515_CR11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1464-410X.1994.tb07634.x","volume":"73","author":"CL Parsons","year":"1994","unstructured":"Parsons CL, Housley T, Schmidt JD, Lebow D (1994) Treatment of interstitial cystitis with intravesical heparin. Br J Urol 73:504\u2013507","journal-title":"Br J Urol"},{"key":"515_CR12","first-page":"1454","volume":"9","author":"G Steinhoff","year":"2002","unstructured":"Steinhoff G, Ittah B, Rowan S (2002) The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol 9:1454\u20131458","journal-title":"Can J Urol"},{"key":"515_CR13","first-page":"1","volume":"84","author":"E Palylyk-Colwell","year":"2006","unstructured":"Palylyk-Colwell E (2006) Chondroitin sulfate for interstitial cystitis. Issues Emerg Health Technol 84:1\u20134","journal-title":"Issues Emerg Health Technol"},{"key":"515_CR14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000283012","volume":"59","author":"D Porru","year":"1997","unstructured":"Porru D, Campus G, Tudino D, Valdes E, Vespa A, Scarpa RM, Usai E (1997) Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol Int 59:26\u201329","journal-title":"Urol Int"},{"key":"515_CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/00365590410015876-1","volume":"39","author":"EB Kallestrup","year":"2005","unstructured":"Kallestrup EB, Steinunn S, J\u00f8rgense S, Nordling J, Hald T (2005) Treatment of interstitial cystitis with Cystistat\u00ae: a hyaluronic acid product. Scand J Urol Nephrol 39:143\u2013147","journal-title":"Scand J Urol Nephrol"},{"key":"515_CR16","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1464-410X.2004.04850.x","volume":"93","author":"C Constantinides","year":"2004","unstructured":"Constantinides C, Manousakas T, Nikolopoulos P, Stanitsas A, Haritopoulos K, Giannopoulos A (2004) Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study. BJU Intern 93:1262\u20131266","journal-title":"BJU Intern"},{"key":"515_CR17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijrobp.2005.09.016","volume":"64","author":"A Manas","year":"2006","unstructured":"Manas A, Glaria L, Pena C, Sotoca A, Lanzos E, Fernandez C, Riviere M (2006) Prevention of urinary tract infection in palliative radiation for vertebral metastasis and spinal compression: a pilot study in 71 patients. Int J Radiation Oncology Biol Phys 64:935\u2013940","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"515_CR18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.ju.0000081163.46167.82","volume":"170","author":"LK Daha","year":"2003","unstructured":"Daha LK, Riedl CR, Hohlbrugger G, Knoll M, Engelhardt PF, Pfluger H (2003) Comparative assessment of maximal bladder capacity, 0.9% NaCL versus 0.2M KCl, for the diagnosis of interstitial cystitis: a prospective controlled study. J Urol 170:807\u2013809","journal-title":"J Urol"},{"key":"515_CR19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1464-410X.2005.05776.x","volume":"96","author":"SK Gupta","year":"2005","unstructured":"Gupta SK, Pidcock L, Parr NJ (2005) The potassium sensitivity test: a predictor of treatment response in interstitial cystitis. BJU Intern 96:1063\u20131066","journal-title":"BJU Intern"},{"key":"515_CR20","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0022-5347(05)68801-5","volume":"161","author":"JM Teichman","year":"1999","unstructured":"Teichman JM, Nielsen-Omeis BJ (1999) Potassium leak test predicts outcome in interstitial cystitis. J Urol 161:1791\u20131796","journal-title":"J Urol"},{"issue":"Suppl4","key":"515_CR21","first-page":"534A","volume":"136","author":"L Daha","year":"2005","unstructured":"Daha L, Riedl CR, Lazar D, Hohlbrugger G, Pfl, ger H (2005) Comparative assessment of maximal bladder capacity 0.9% vs. 0.2\u00a0M KCl, before and after therapy for interstitial cystitis. Eur Urol 136(Suppl4):534A","journal-title":"Eur Urol"},{"key":"515_CR22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0090-4295(01)01586-2","volume":"59","author":"CL Parsons","year":"2002","unstructured":"Parsons CL, Forrest J, Nickel CJ, Elmiron Study Group (2002) Effect of pentosan polysulfate therapy on intravesical potassium sensitivity. Urology 59:329\u2013334","journal-title":"Urology"},{"key":"515_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/abbi.1996.0238","volume":"330","author":"MS Buckley","year":"1996","unstructured":"Buckley MS, Washington S, Laurent C, Erickson DE, Bhavanandan VP (1996) Characterization and immunohistochemical localization of the glycoconjugates of the rabbit bladder mucosa. Arch Biochem Biophys 330:163\u2013173","journal-title":"Arch Biochem Biophys"},{"key":"515_CR24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0090-4295(02)01613-8","volume":"60","author":"M Leppilahti","year":"2002","unstructured":"Leppilahti M, Hellstr\u00f6m P, Tammela TLJ (2002) Effect of diagnostic hydrodistension and four intravesical hyaluronan instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology 60:46\u201351","journal-title":"Urology"},{"key":"515_CR25","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0022-5347(05)65726-6","volume":"166","author":"Y Sun","year":"2001","unstructured":"Sun Y, Keay S, De Deyne PG, Chai TC (2001) Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis. J Urol 166:1951\u20131954","journal-title":"J Urol"},{"key":"515_CR26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0022-5347(05)64909-9","volume":"168","author":"PS Sadhukan","year":"2002","unstructured":"Sadhukan PS, Tchetgen MB, Rackley RR, Vasavada SP, Liou L, Bandyopadhyay SK (2002) Sodium pentosan polysulfate reduces urothelial responses to inflammatory stimuli via an indirect mechanism. J Urol 168:289\u2013292","journal-title":"J Urol"},{"key":"515_CR27","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/01.ju.0000083020.06212.3d","volume":"170","author":"GR Sant","year":"2003","unstructured":"Sant GR, Propert KJ, Hanno PM, Interstitial Cystitis Clinical Trials Group (2003) A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol 170:810\u2013813","journal-title":"J Urol"},{"key":"515_CR28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1464-410X.1997.03384.x","volume":"79","author":"JJ Bade","year":"1997","unstructured":"Bade JJ, Laseur M, Nieuwenburg A, van der Weele LT, Mensink HJ (1997) A placebo controlled study of intravesical pentosan polysulfate for the treatment of interstitial cystitis. Br J Urol 79:168\u2013171","journal-title":"Br J Urol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-007-0515-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-007-0515-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-007-0515-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T10:50:45Z","timestamp":1558608645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-007-0515-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,21]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1007\/s00192-007-0515-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1099064.555263","asserted-by":"object"}]},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,21]]}}}